Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.27 +0.08 (+0.42%)
As of: Oct 22, 2026 · 11:09 AM EDT

Acadia Pharmaceuticals (ACAD) Return on Assets [ROA] (2011 - 2026)

Updated

Acadia Pharmaceuticals (ACAD) reported Return on Assets [ROA] of 22.73% for Q2 2026, up 3.88 percentage points from 18.85% a year earlier but down 0.98 percentage points from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025, Acadia Pharmaceuticals posted Return on Assets [ROA] of 28.42%, up 5.03 percentage points from FY2024.

  • Return on Assets [ROA] has increased for three consecutive years, with a five-year change of +64.38 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at 23.39% in FY2024 (+32.55 pp), -9.17% in FY2023 (+24.37 pp), -33.54% in FY2022 (-10.89 pp) and -22.64% in FY2021 (+13.32 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -36.30% in Q4 2022 and a high of 27.01% in Q4 2025.
  • Year over year, Return on Assets [ROA] has now increased in each of the last 14 quarters, with an average year-over-year change of +15.36 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q3 2024 (a gain of 36.92 percentage points); the low point was Q4 2022 (a drop of 12.62 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 23.71% (Q1 2026), 27.01% (Q4 2025) and 20.44% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn 10.47%
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn 4.65%
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn 2.45%
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 9.10%
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 9.29%
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -6.13%
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 2.14%
10 Acadia Pharmaceuticals 3.48 Bn 1.18 Mn 279.64 Mn 22.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.73%
Mar 31, 2026 23.71%
Dec 31, 2025 27.01%
Sep 30, 2025 20.44%
Jun 30, 2025 18.85%
Mar 31, 2025 19.73%
Dec 31, 2024 20.92%
Sep 30, 2024 13.59%
Jun 30, 2024 3.46%
Mar 31, 2024 -0.21%
Dec 31, 2023 -8.87%
Sep 30, 2023 -23.33%
Jun 30, 2023 -17.07%
Mar 31, 2023 -23.48%
Dec 31, 2022 -36.30%
Sep 30, 2022 -35.79%
Jun 30, 2022 -33.09%
Mar 31, 2022 -32.40%
Dec 31, 2021 -23.68%
Sep 30, 2021 -26.56%
API Access

Acadia Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACAD&period=max&api_key=YOUR_API_KEY